Population-based meta-analysis of chloroquine: informing chloroquine pharmacokinetics in COVID-19 patients

AIMS: Chloroquine (CQ) has been repurposed to treat coronavirus disease 2019 (COVID-19). Understanding the pharmacokinetics (PK) in COVID-19 patients is essential to study its exposure–efficacy/safety relationship and provide a basis for a possible dosing regimen optimization. SUBJECT AND METHODS: I...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Xueting, Yan, Xiaoyu, Wang, Xiaohan, Cai, Ting, Zhang, Shun, Cui, Cheng, Wang, Xiaoxu, Hou, Zhe, Liu, Qi, Li, Haiyan, Lin, Jing, Xiong, Zi, Liu, Dongyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Pharmacokinetics and Disposition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665884/
https://www.ncbi.nlm.nih.gov/pubmed/33188451
http://dx.doi.org/10.1007/s00228-020-03032-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665884/
https://www.ncbi.nlm.nih.gov/pubmed/33188451
http://dx.doi.org/10.1007/s00228-020-03032-6

Ejemplares similares